國立虎尾科技大學 |

Precision Molecular Pathology of Prostate Cancer

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Precision Molecular Pathology of Prostate Cancer/ edited by Brian D. Robinson, Juan Miguel Mosquera, Jae Y. Ro, Mukul Divatia.
other author:	Robinson, Brian D.
Description:	XIV, 570 p. 50 illus., 48 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Pathology. -
Online resource:	https://doi.org/10.1007/978-3-319-64096-9
ISBN:	9783319640969

Precision Molecular Pathology of Prostate Cancer
Precision Molecular Pathology of Prostate Cancer[electronic resource] /edited by Brian D. Robinson, Juan Miguel Mosquera, Jae Y. Ro, Mukul Divatia. - 1st ed. 2018. - XIV, 570 p. 50 illus., 48 illus. in color.online resource. - Molecular Pathology Library,1935-987X. - Molecular Pathology Library,10.

Part I. General principles -- Approach to patient -- Etiology -- Precursor and pre-invasive lesions of prostate cancer -- Prostatic adenocarcinoma: morphologic spectrum, Gleason scoring, etc -- Genetic susceptibility -- DNA damage repair, BRCA mutations, DNA adducts, SNPs -- Racial differences -- Cancer stem cells Part II. Molecular signatures of primary prostate cancer -- SNPs -- Copy number variation/chromosomal aberration (PTEN deletion, etc.) -- Gene fusions (TMPRSS2:ERG, etc.) -- Gene expression arrays -- Next generation sequencing (point mutations, indels, etc.) -- Epigenetic changes (chromatin remodeling, etc.) -- Proteomics -- Metabolomics -- miRNA and lncRNA Part III. Molecular signatures of advanced prostate cancer -- Lymph node metastasis -- Bone metastasis a -- RANKL, Src kinases, endothelins, bisphosphonates -- Visceral metastasis a -- Role of extracellular matrix, angiogenesis, epithelial-mesenchymal transition (EMT), inflammation -- Castration resistant prostate cancer (CRPC) -- Neuroendocrine prostate cancer (NEPC) Part IV. Key molecular pathways in prostate cancer development and progression -- Androgen receptor in carcinogenesis -- Androgen receptor in progression (CRPC) -- PI3K/Akt/mTOR/PTEN and ERK/MAPK pathways -- Cell cycle regulators (p53, etc.) -- DNA damage repair -- Tyrosine kinase signaling (EGFR, VEGFR, PDGFR, FGFR, IGFR, etc.) -- Cytoskeletal function (microtubules and taxane therapy) Part V. Precision medicine approach: Diagnosis, treatment, prognosis -- Molecular diagnosis -- Molecular imaging -- Molecular prognostic markers/tests -- Molecular targeted therapies -- Towards molecular classification of prostate cancer.

This volume focuses on our current understanding of the molecular underpinnings of prostate cancer and their potential application for precision medicine approaches. The emergence and applications of new technologies has allowed for a rapid expansion of our understanding of the molecular basis of prostate cancer and has revealed a remarkable genetic heterogeneity that may underlie the clinically variable behavior of the disease. The book consists of five sections which provide insight about the following: (1) General principles; (2) Molecular signatures of primary prostate cancer; (3) Molecular signatures of advanced prostate cancer; (4) Key molecular pathways in prostate cancer development and progression; (5) Precision medicine approach: Diagnosis, treatment, prognosis. Precision Molecular Pathology of Prostate Cancer is an important resource for the practicing oncologist, urologist, and pathologist, and will also be useful for researchers in the prostate cancer community. .

ISBN: 9783319640969

Standard No.: 10.1007/978-3-319-64096-9doiSubjects--Topical Terms:

668553
Pathology.

LC Class. No.: RB1-214

Dewey Class. No.: 616.07

Precision Molecular Pathology of Prostate Cancer
LDR:04130nam a22004095i 4500 001 991569
003 DE-He213
005 20200701174401.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319640969 $9 978-3-319-64096-9
024 7 $a 10.1007/978-3-319-64096-9 $2 doi
035 $a 978-3-319-64096-9
050 4 $a RB1-214
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
072 7 $a MKF $2 thema
082 0 4 $a 616.07 $2 23
245 1 0 $a Precision Molecular Pathology of Prostate Cancer $h [electronic resource] / $c edited by Brian D. Robinson, Juan Miguel Mosquera, Jae Y. Ro, Mukul Divatia.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XIV, 570 p. 50 illus., 48 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Molecular Pathology Library, $x 1935-987X
505 0 $a Part I. General principles -- Approach to patient -- Etiology -- Precursor and pre-invasive lesions of prostate cancer -- Prostatic adenocarcinoma: morphologic spectrum, Gleason scoring, etc -- Genetic susceptibility -- DNA damage repair, BRCA mutations, DNA adducts, SNPs -- Racial differences -- Cancer stem cells Part II. Molecular signatures of primary prostate cancer -- SNPs -- Copy number variation/chromosomal aberration (PTEN deletion, etc.) -- Gene fusions (TMPRSS2:ERG, etc.) -- Gene expression arrays -- Next generation sequencing (point mutations, indels, etc.) -- Epigenetic changes (chromatin remodeling, etc.) -- Proteomics -- Metabolomics -- miRNA and lncRNA Part III. Molecular signatures of advanced prostate cancer -- Lymph node metastasis -- Bone metastasis a -- RANKL, Src kinases, endothelins, bisphosphonates -- Visceral metastasis a -- Role of extracellular matrix, angiogenesis, epithelial-mesenchymal transition (EMT), inflammation -- Castration resistant prostate cancer (CRPC) -- Neuroendocrine prostate cancer (NEPC) Part IV. Key molecular pathways in prostate cancer development and progression -- Androgen receptor in carcinogenesis -- Androgen receptor in progression (CRPC) -- PI3K/Akt/mTOR/PTEN and ERK/MAPK pathways -- Cell cycle regulators (p53, etc.) -- DNA damage repair -- Tyrosine kinase signaling (EGFR, VEGFR, PDGFR, FGFR, IGFR, etc.) -- Cytoskeletal function (microtubules and taxane therapy) Part V. Precision medicine approach: Diagnosis, treatment, prognosis -- Molecular diagnosis -- Molecular imaging -- Molecular prognostic markers/tests -- Molecular targeted therapies -- Towards molecular classification of prostate cancer.
520 $a This volume focuses on our current understanding of the molecular underpinnings of prostate cancer and their potential application for precision medicine approaches. The emergence and applications of new technologies has allowed for a rapid expansion of our understanding of the molecular basis of prostate cancer and has revealed a remarkable genetic heterogeneity that may underlie the clinically variable behavior of the disease. The book consists of five sections which provide insight about the following: (1) General principles; (2) Molecular signatures of primary prostate cancer; (3) Molecular signatures of advanced prostate cancer; (4) Key molecular pathways in prostate cancer development and progression; (5) Precision medicine approach: Diagnosis, treatment, prognosis. Precision Molecular Pathology of Prostate Cancer is an important resource for the practicing oncologist, urologist, and pathologist, and will also be useful for researchers in the prostate cancer community. .
650 0 $a Pathology. $3 668553
650 0 $a Oncology . $3 1253469
650 0 $a Urology. $3 645258
650 2 4 $a Oncology. $3 593951
700 1 $a Robinson, Brian D. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1283262
700 1 $a Mosquera, Juan Miguel. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1283263
700 1 $a Ro, Jae Y. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 793026
700 1 $a Divatia, Mukul. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1283264
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319640945
776 0 8 $i Printed edition: $z 9783319640952
776 0 8 $i Printed edition: $z 9783319877211
830 0 $a Molecular Pathology Library, $x 1935-987X ; $v 10 $3 1262700
856 4 0 $u https://doi.org/10.1007/978-3-319-64096-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)